Publicaciones en las que colabora con ANGEL LUIS GUERRERO PERAL (82)

2024

  1. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 4

  2. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study

    Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202

  3. Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study

    European Journal of Neurology, Vol. 31, Núm. 5

  4. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

    Journal of Headache and Pain, Vol. 25, Núm. 1

  5. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

2023

  1. Cefalea: concepto, diagnóstico, criterios de alerta y exploraciones complementarias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 71, pp. 4143-4152

  2. Connectivity-based Meta-Bands: A new approach for automatic frequency band identification in connectivity analyses

    NeuroImage, Vol. 280

  3. Diferencias y similitudes entre la cefalea relacionada con la COVID-19 y la cefalea relacionada con la vacuna de la COVID-19. Un estudio de casos y controles

    Revista de neurologia, Vol. 77, Núm. 10, pp. 229-239

  4. Increased MRI-based Brain Age in chronic migraine patients

    Journal of Headache and Pain, Vol. 24, Núm. 1

  5. InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection

    Cephalalgia : an international journal of headache, Vol. 43, Núm. 11

  6. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

  7. Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up

    Cephalalgia : an international journal of headache, Vol. 43, Núm. 9

  8. Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data

    Current Pain and Headache Reports

  9. Structural brain changes in patients with persistent headache after COVID-19 resolution

    Journal of Neurology, Vol. 270, Núm. 1, pp. 13-31

  10. Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headache

    Neurologia, Vol. 38, Núm. 4, pp. 270-277

  11. Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, Núm. 9, pp. 635-646

  12. Treatment of Primary Nummular Headache: A Series of 183 Patients from the NUMITOR Study

    Journal of Clinical Medicine, Vol. 12, Núm. 1

  13. Viability of AMURA biomarkers from single-shell diffusion MRI in clinical studies

    Frontiers in Neuroscience, Vol. 17

2022

  1. Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors

    Journal of Neurology, Vol. 269, Núm. 11, pp. 5702-5709

  2. Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 7